Sabril Interactions
There are 287 drugs known to interact with Sabril (vigabatrin), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 35 are major, 247 are moderate, and 5 are minor.
- View all 287 medications that may interact with Sabril
- View Sabril alcohol/food interactions (1)
- View Sabril disease interactions (4)
Most frequently checked interactions
View interaction reports for Sabril (vigabatrin) and the medicines listed below.
- Actemra (tocilizumab)
- albuterol
- azithromycin
- baclofen
- Banzel (rufinamide)
- Blincyto (blinatumomab)
- clobazam
- clonazepam
- clonidine
- Diastat (diazepam)
- diazepam
- Esbriet (pirfenidone)
- famotidine
- gabapentin
- ibuprofen
- Imbruvica (ibrutinib)
- Keppra (levetiracetam)
- Lamictal (lamotrigine)
- levetiracetam
- melatonin
- MiraLAX (polyethylene glycol 3350)
- Nexium (esomeprazole)
- Ofev (nintedanib)
- Onfi (clobazam)
- Prevacid (lansoprazole)
- Topamax (topiramate)
- Tylenol (acetaminophen)
- valproic acid
- Vimpat (lacosamide)
- Vitamin B6 (pyridoxine)
Sabril alcohol/food interactions
There is 1 alcohol/food interaction with Sabril (vigabatrin).
Sabril disease interactions
There are 4 disease interactions with Sabril (vigabatrin) which include:
Report options
QR code containing a link to this page
More about Sabril (vigabatrin)
- Sabril consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: gamma-aminobutyric acid analogs
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
